Clinical Trial Update: A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating GR2001 Injection for tetanus is currently recruiting, with planned assessments of efficacy, safety, pharmacokinetics, and im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• GR2001 Injection

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Tetanus | Phase 3 | Status: RECRUITING